SITC-NCI Computational Immuno-Oncology Webinar Series: Utilizing Correlative Studies for Drug Development
In partnership with NCI’s Cancer MoonshotSM Initiative, the Society for Immunotherapy of Cancer (SITC) and the Big Data and Data Sharing Committee are hosting the fourth of nine webinars that make up the 2022 SITC-NCI Computational Immuno-Oncology Webinar Series. Dr. Lillian L. Siu of the Princess Margaret Cancer Centre will be presenting, “Utilizing Correlative Studies for Drug Development: Computational Science in Immuno-Oncology.” The discussion will be moderated by Dr. Dora Hammerl of Erasmus MC Cancer Institute.
The SITC-NCI Computational Immuno-Oncology Webinar Series consists of nine, hour-long courses featuring a moderator and faculty speaker to lead instruction. Topics will cover a host of computational challenges of analyzing and integrating diverse assay data across the spectrum of immuno-oncology. This series is intended for scientists early in their career and/or those who want to remain abreast of the latest technologies. These webinars were created to foster better communication concerning data science technologies and analyses between cancer immunotherapy researchers and clinicians to advance translational immunotherapy research.
Dr. Siu is a senior scientist at the Princess Margaret Cancer Centre. Here, she works as the director of the Phase I Program, co-director of the Bras and Family Drug Development Program, and the clinical lead for the Tumor Immunotherapy Program.
Dr. Hammerl is a postdoctoral researcher at Erasmus MC Cancer Institute.